Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Capital Expenditures

Acadia Pharmaceutica Capital Expenditures Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Capital Expenditures from 2011 to 2020.
  • Acadia Pharmaceutica Capital Expenditures for the quarter ending June 06, 2020 was $-3m a 97.27% decrease of -3m year over year
  • Acadia Pharmaceutica Capital Expenditures for the last 12 months ending June 06, 2020 was $-4m a 64.08% decrease of -3m year over year
  • Acadia Pharmaceutica Annual Capital Expenditures for 2019 was $-1m a -90.26% increase of 1m from 2018
  • Acadia Pharmaceutica Annual Capital Expenditures for 2018 was $-2m a 62.20% decrease of -1m from 2017
  • Acadia Pharmaceutica Annual Capital Expenditures for 2017 was $-1m a -85.47% increase of 1m from 2016
Other Cash Flow Metrics:
  • Acadia Pharmaceutica Cash Flow from Operations for the quarter ending September 09, 2018 was $-42m a 29.29% decrease of -12m year over year
  • Acadia Pharmaceutica Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-22m a 80.38% decrease of -17m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD Capital Expenditures Data

06/2020$-3m
03/2020$-1m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$-1m
12/2018$-1m
09/2018$-1m
06/2018$0m
03/2018$0m

Annual ACAD Capital Expenditures Data

2019$-1m
2018$-2m
2017$-1m
2016$-2m
2015$-2m
2014$0m
2013$-1m
2011$0m